Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
US6379667B1 · kind B1 · utility
3Cited by
2References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 3, 1999 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | Aug 3, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/782
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of an MMP inhibitor, especially a collagenase inhibitor, in the manufacture of a medicament for the treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction of the tissue and methods for the treatment of tissue comprising extracellular matrix components to inhibit contraction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.